L26/P-402 Oocyte-secreted protein 2 enhances in vitro maturation of ovarian tissue oocytes for fertility preservation via cumulus-oocyte crosstalk
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von X. Pan und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does oocyte-secreted protein 2 (OOSP2) supplementation enhance maturation rates in patients undergoing ovarian tissue oocyte in vitro maturation (OTO-IVM) for fertility preservation? Summary answer OOSP2 supplementation significantly improves oocyte maturation rates across all ages by restoring cumulus cell gonadotropin sensitivity and coordinating nuclear-cytoplasmic maturation via cGMP-PKG signaling. What is known already Recovery of immature oocytes from ovarian tissue followed by in vitro maturation is a critical alternative strategy for fertility preservation, especially for pre-pubertal girls and patients ineligible for ovarian stimulation. However, oocyte maturation efficiency often remains suboptimal due to the interruption of physiological signaling. Oocyte-secreted factors are fundamental in regulating cumulus cell differentiation and supporting the acquisition of oocyte developmental competence.While OOSP2 is known to enhance maturation during rescue-IVM of immature oocytes from intracytoplasmic sperm injection cycles via small GTPase signaling pathways, its specific role and clinical utility in OTO-IVM for fertility preservation remain unknown. Study design, size, duration This retrospective cohort study was conducted between April 2019 and June 2024 involving 187 patients undergoing fertility preservation. The study design integrated a clinical outcome analysis of IVM cycles with molecular mechanistic investigations to comprehensively evaluate the efficacy and biological basis of the intervention. Participants/materials, setting, methods Patients with malignant tumors or hematological diseases underwent fertility preservation at a tertiary care medical center. Oocytes were cultured in a biphasic IVM system with or without OOSP2 supplementation. The primary outcome was the maturation rate. Mechanistically, transcriptomic analysis was performed on metaphase II oocytes and associated cumulus cells to elucidate the underlying signaling pathways. Main results and the role of chance The oocyte maturation rate was significantly higher in the OOSP2 group compared with the control group (52.8% vs. 42.7%; P<.001). After adjustment for confounders including age, BMI, AMH, menarche status, and Gn stimulation, OOSP2 remained beneficial (adjusted odds ratio [aOR] 1.69; 95% CI 1.33-2.16). Subgroup analysis demonstrated consistent benefits across all developmental stages, with significant improvements in pre-menarchal children aged ≤10 years (aOR 1.60; 95% CI 1.11-2.29), pre-menarchal adolescents aged 11-18 years (aOR 1.54; 95% CI 1.01-2.35), post-menarchal adolescents (aOR 2.81; 95% CI 1.31-6.01), and adults (aOR 2.00; 95% CI 1.09-3.65). Transcriptomic analysis revealed that OOSP2 enhanced cytoskeletal competence and reduced oxidative stress signatures in oocytes. In cumulus cells, OOSP2 exerted a dual regulatory effect: it significantly upregulated gonadotropin receptors to restore hormonal sensitivity and modulated stage-dependent signaling. Specifically, it reinforced cGMP-PKG pathways during the pre-IVM phase while promoting steroidogenesis and cumulus expansion in the IVM phase. These molecular findings align with the observed clinical improvement. Limitations, reasons for caution This is a retrospective study within a single center, which may introduce selection bias. While oocyte maturation improved, data regarding fertilization, embryo quality, and live birth rates were not evaluated in this study and require further longitudinal follow-up. Wider implications of the findings Integrating OOSP2 into biphasic IVM systems represents a significant advancement in optimizing fertility preservation, including the challenging pre-menarchal population. Mechanistically, restoring physiological cumulus-oocyte crosstalk supports OOSP2 supplementation as a promising strategy to improve the efficiency of assisted reproductive technologies. Trial registration number No
Zitieren
APA
Pan, X., Sun, P., Guo, J., Kee, K., Liang, X., & Zeng, H. (2026). L26/P-402 Oocyte-secreted protein 2 enhances in vitro maturation of ovarian tissue oocytes for fertility preservation via cumulus-oocyte crosstalk. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.736
Vancouver
Pan X, Sun P, Guo J, Kee K, Liang X, Zeng H. L26/P-402 Oocyte-secreted protein 2 enhances in vitro maturation of ovarian tissue oocytes for fertility preservation via cumulus-oocyte crosstalk. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.736
BibTeX
@article{Pan2026,
author = {Pan, X. and Sun, P. and Guo, J. and Kee, K. and Liang, X. and Zeng, H.},
title = {L26/P-402 Oocyte-secreted protein 2 enhances in vitro maturation of ovarian tissue oocytes for fertility preservation via cumulus-oocyte crosstalk},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.736}
}
EUVIMED